Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Doximity (DOCS) EBITDA (2020 - 2025)

Doximity (DOCS) has disclosed EBITDA for 6 consecutive years, with $71.9 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA fell 10.05% to $71.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $238.8 million, a 8.06% increase, with the full-year FY2025 number at $227.8 million, up 39.01% from a year prior.
  • EBITDA was $71.9 million for Q4 2025 at Doximity, up from $63.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $79.9 million in Q4 2024 to a low of $21.7 million in Q2 2022.
  • A 5-year average of $42.2 million and a median of $37.1 million in 2021 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: skyrocketed 1094.19% in 2021, then fell 12.84% in 2022.
  • Doximity's EBITDA stood at $35.8 million in 2021, then increased by 7.53% to $38.5 million in 2022, then soared by 52.14% to $58.6 million in 2023, then skyrocketed by 36.5% to $79.9 million in 2024, then dropped by 10.05% to $71.9 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's EBITDA are $71.9 million (Q4 2025), $63.7 million (Q3 2025), and $54.5 million (Q2 2025).